Having worked across both the pharmaceutical and natural supplementary products arenas for nearly 30 years along with years of research as chief scientist at Plant and Food Research screening millions of plants and botanicals, Dr Weir created a range of high-performance natural skincare products that transform skin deep within.
Dr Weir launched the Atopis® Skincare range in 2017, holding global patents for her clinically proven skincare that treat common skincare issues like rosacea, acne, pigmentation, skin ageing and eczema.
Dr Weir’s vision was to create a multi-faceted botanical ferment that would effectively rebalance the skin microbiome, slow cell death, and boost immune function at cell level to transform skin deep within.
In the lab, Dr Weir invented a novel fermentation technology using plant enzymes to bring this vision to life. The result is the patented manufacturing technology Myriphytase® and from this process Myrecil™, the patented botanical ferment that is now the foundational ingredient in all Atopis products.
Myriphytase®, a completely natural manufacturing technology, is used to synergistically fuse the Myrecil™ botanical ferment into the skin cream base with other plant extracts without the use of excess heat, preservatives or radiation. This is crucial to retaining the natural integrity of the ferment within the high-performance skincare creams in the Atopis® skincare range.
The technology behind Atopis® is covered by a suite of globally granted patents. Dr Weir has also developed and patented Peptilipids™, a polymolecular complex that is created during this botanical fermentation process.
Myrecil™ has been scientifically proven to have greater efficacy to topical retinoids, but does not contain any retinoids; meaning Atopis Skincare does not cause the side effects of retinol, yet gives all of the benefits! This is groundbreaking science. Retinoids are popular in the cosmetic industry due to their ability to slow cell division and death and increase immune function, but they can trigger side effects such as redness, irritation, sun sensitivity and itching.
Using high-tech cellular science the botanical ferment Myrecil™ has been scientifically proven to create retinoid-like activity in the skin cell, boost hyaluronic acid in skin cells, rebalance the microbiome, alter cellular immune responses and promote cell renewal.
Two clinical trials were undertaken in 2017 to test the efficacy of Atopis® products, the first in the United States and the second in New Zealand in conjunction with St Andrews University, Scotland.
Following the success of these trials and the extensive science and clinical portfolio of data, Atopis® achieved Over The Counter Pharmacy registration in the United States for the Atopis® Eczema Therapy cream and began selling in 2019. Achieving this registration required that Atopis® pass the US Good Manufacturing Practice manufacturing requirements for an OTC product, whilst also remaining 100% natural. In order to achieve this registration, Dr Weir invented a novel manufacturing process that eliminates the need for excess heat, extra preservatives or irradiation to protect the quality of these high-performance skincare products.
In 2021, Decima will register other Atopis® creams targeting rosacea, acne and psoriasis for sale in the OTC market in the US, as well as expand the Atopis® range and isolate and structurally elucidate (isolate to one cell) the patented complex responsible for the retinoid-like activity. While the US OTC creams are not available in New Zealand or Australia, Atopis® will be releasing OTC creams for the Australian and New Zealand markets in the next 12 months.
Natural skincare and sustainability go hand in hand. Atopis® Skincare is Made in New Zealand using the power of potent botanical ingredients and science and is free of parabens, fillers, solvents, fragrance, silicone, SLS or synthetic chemicals. It is clinically trialed on humans, not on animals.